| Dr Carol S Wood, PHD | |
|
2101 4th Ave E, Olympia, WA 98506-6512 | |
| (360) 786-9499 | |
| (360) 786-0758 |
| Full Name | Dr Carol S Wood |
|---|---|
| Gender | Female |
| Speciality | Psychologist - Clinical |
| Location | 2101 4th Ave E, Olympia, Washington |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1023124021 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 103TC0700X | Psychologist - Clinical | PY1786 (Washington) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Dr Carol S Wood, PHD 2101 4th Ave E, Olympia, WA 98506-6512 Ph: (360) 786-9499 | Dr Carol S Wood, PHD 2101 4th Ave E, Olympia, WA 98506-6512 Ph: (360) 786-9499 |
News Archive
A new study presented at the Society of NeuroInterventional Surgery's 13th Annual Meeting in Boston found that the Opercular Score Index (OIS) is a practical, noninvasive scoring system that can be used to predict the strength and health of the vascular network in the brain (known as collateral robustness) and good clinical outcome among stroke patients undergoing endovascular recanalization.
Mersana Therapeutics, a platform-based cancer therapeutics company, announced today additional preliminary results from an ongoing Phase 1 study of its lead development candidate, XMT-1001, in patients with advanced solid tumors.
Using a first-of-its-class drug in a clinical trial, an international research effort headed by a scientist at University of California San Diego School of Medicine reports that inhibition of a key enzyme safely and effectively improved the health of persons with non-alcoholic fatty liver disease, a chronic metabolic disorder that affects hundreds of millions of people worldwide.
Scientists of the Luxembourg Institute of Health have discovered a so far unknown molecular mechanism by which the human immune system activates its immune cells: T cells, a particular type of white blood cells, effectively ward off pathogens if a gene known as Gclc is expressed within them.
The first patient has been enrolled, in Hamburg, Germany, for the largest pan-European study to determine whether an early comprehensive rhythm control strategy for the treatment of atrial fibrillation (AF) will benefit patients.
› Verified 8 days ago
Dr. Lori Woehler, PSYD Psychologist Medicare: Not Enrolled in Medicare Practice Location: 9101 Steilacoom Rd Se Unit 26, Olympia, WA 98513 Phone: 425-785-1553 | |
Ms. Dana Elise Shaw, MD Psychologist Medicare: Accepting Medicare Assignments Practice Location: 3436 Mary Elder Rd Ne, Olympia, WA 98506 Phone: 360-528-2590 | |
Dr. David Peter Monson, PH.D. Psychologist Medicare: Not Enrolled in Medicare Practice Location: 2633a Parkmont Ln Sw, Ste F, Olympia, WA 98502 Phone: 360-870-8744 Fax: 360-352-3289 | |
Xinyi Liu, DBH, RDN Psychologist Medicare: Medicare Enrolled Practice Location: 3435 Martin Way E Ste C, Olympia, WA 98506 Phone: 786-838-3890 | |
Dr. Terilee Wingate, PH.D. Psychologist Medicare: Not Enrolled in Medicare Practice Location: 3430 Pacific Ave Se Ste A6, Pmb 308, Olympia, WA 98501 Phone: 360-789-7918 | |
Dr. John Richter Van Eenwyk, PHD Psychologist Medicare: Not Enrolled in Medicare Practice Location: 1026 State Ave Ne, Olympia, WA 98506 Phone: 360-352-2974 |